• Chronic Myeloid Leukemia
• Hodgkin's and Non-Hodgkin's lymphoma

Dr. Chen is the Director for the BMT program at MGH. His research interests mainly revolve around improving the outcomes for patients undergoing autologous and allogeneic stem cell transplantation. He serves as institution and overall principal investigator for many clinical trials.